RxPG - the perfect Rx for medical Post Graduate entrance blues!
Mobile Edition | Help/Newbie? | 24/7 Support
HOT | PrePG | MCQ | DNB | Careers | Books | Colleges | Dental | DocIndia | PLAB |  USMLE  | Australia | Canada | GLOBAL | OffBeat!
Articles | Forums | MCQ Crammer | Downloads | Mnemonics | Revision Tools | Recent Shouts | All Features


Amenorrhoea

Author: Hanna, Posted on Tuesday, May 18 @ 19:18:15 IST by RxPG  

 FRIEND Add to My Pages   PRINTER Printer Friendly   FRIEND Email Story  FRIEND Download Story  PLAB Part 1 alerts 

PLAB Part 1

Amenorrhoea is nearly always endocrine in origin, and associated with anovulation and infertility.

Anatomical defects account for about 1% of cases. Some of these patients may be ovulating normally, but the bleeding is concealed.

anatomical

Congenital causes include:

intersex states - usually the effect of an underlying endocrine order such as congenital adrenal hyperplasia; for example, true hermaphroditism, and male or female pseudohermaphroditism
malformation of the female genital tract - such as uterine agenesis, vaginal atresia, imperforate hymen
Acquired causes include:

endometrial fibrosis - Asherman's syndrome, tuberculosis; both rare in the UK
cervical stenosis - usually due to surgery, especially cautery or conization

endocrine

Many endocrine disorders can cause amenorrhoea. The most common causes are functional disorders of the hypothalamus and hyperprolactinaemia.

Hypothalamic disorders:

hypogonadotrophic hypogonadism - e.g. Kallmann's syndrome
psychogenic - associated with emotional stress, shift work especially, night / day shifts
exercise
excessive weight gain / weight loss
tumours - e.g. craniopharyngioma
post-oral contraceptive use - "post-pill amenorrhoea"
Pituitary lesions:

tumours - with or without hyperprolactinaemia; includes prolactin secreting pituitary adenomas, non-functional pituitary adenomas with suprasellar extension impairing blood flow down the pituitary stalk; growth hormone secreting tumours - 30% secrete prolactin
infarction necrosis - Sheehan's syndrome
granulomatous infiltration - e.g. sarcoidosis
Ovarian lesions:

ovarian dysgenesis - Turner's syndrome / mosaic
polycystic ovarian syndrome
resistant ovary syndrome
premature ovarian failure
androgen secreting ovarian tumours
surgery - oophorectomy; ovarian suppression by pelvic irradiation
Other endocrine lesions:

thyroid - primary hypothyroidism; hyperthyroidism
pancreas - poorly controlled diabetes
adrenal - Cushing's syndrome; advanced Addison's disease

primary versus secondary amenorrhoea


The causes of primary and secondary amenorrhoea overlap but the distinction is informative. Secondary amenorrhoea indicates a patent lower genital tract, an endometrium which has responded to ovarian hormones, and ovaries which have responded to gonadotrophins. Exceptions include surgery to the endometrium or cervix which rarely cause intrauterine adhesions or cervical stenosis respectively.

Congenital disorders usually present as primary amenorrhoea, for example:

congenital malformations of the genital tract
testicular feminisation
gonadal dysgenesis
congenital adrenal hyperplasia
hypogonadotrophic hypogonadism
However, any cause of secondary amenorrhoea may present as primary amenorrhoea if it occurs before the age of 16 years.

primary amenorrhoea

This is the failure to start menstruating. If this occurs in a 16 year old (or in a 14 year old who has growth failure or absence of secondary sexual characteristics) then this requires investigation. For menstruation to occur there must be a functioning hypothalmic-pituitary axis and no structural abnormalities that may prevent menstruation e.g. uterine agenesis, imperforate hymen.

secondary amenorrhoea

This occurs when there have been no periods for a period of more than 6 months in a female who has previously had periods (other than due to pregnancy). Commonly secondary amenorrhoea is due to dysfunction of the hypothalmic-pituitary axis. Rarely this condition may due to ovarian or endometrial causes.

amenorrhoea (exercise)

A combination of both stress on the brain and reduced fat mass leading to reduced oestrogen metabolism may lead to amenorrhoea.

This condition is particularly prevalent in ballet schools and college sports. A principal concern in the management is the prevention of osteoporosis, this is combatted using hormone replacement therapy or the oral contraceptive pill - the latter being more socially acceptable to young people with the added advantage of contraception. If restoration of fertility is a main objective, the best treatment is to gain weight.


amenorrhoea (weight loss)


Weight loss leads to reduced fat mass, reduced oestrogen metabolism, and amenorrhoea.

The effects of weight loss on menstruation may be estimated from the Ponteral index which is defined as: Weight in Kg / (Height in Metres, squared)

A ponteral index less than 17 or greater than 25 - 27 predicts amenorrhoea. The range of values at the upper limit arises from the greater unpredictability of obesity on menstruation, except in cases of the polycystic ovarian syndrome.


investigations


Congenital causes of amenorrhoea can be ignored in patients with secondary amenorrhoea but a patient with primary amenorrhoea may have any of the conditions associated with primary or secondary amenorrhoea. Pregnancy must always be excluded.

Basic investigations are:

history and physical examination
hormone measurements - PRL, FSH, LH, thyroid function, testosterone
pelvic ultrasound scan - indicates size of ovaries, presence of follicles and their size, may reveal polycystic ovaries, presence of uterus in cases of vaginal atresia
Other investigations are conducted as indicated:

chromosomal studies - if primary amenorrhoea without any obvious basis or if abnormal phenotype
progesterone challenge
radiologic studies - intravenous urogram if uterine or vaginal malformation to exclude associated renal abnormalities
CT - to visualise pituitary fossa for tumours
laparoscopy and gonadal biopsy - indicated only if the nature of the gonads or the presence of primary oocytes is in dispute
hysteroscopy


hormone measurements


The most important measurements are serum LH, FSH, PRL (x2) and TFTs.

LH is often raised in polycystic ovarian syndrome.

An elevated serum FSH indicates ovarian failure.

Prolactin is raised by stress, prolactinomas and secondary to some drugs e.g. phenothiazines.

A normal FSH may occur in conditions such as PCO, hypothalamic - pituitary lesions, and outflow tract disorders. A progesterone challenge will help discriminate these conditions. A withdrawal bleed after a progesterone challenge indicates anovulation e.g. PCO. No withdrawal bleed after a regime of oestrogen for 21 days then progestogen for 5 days indicates an outflow tract disorder e.g. Asherman's syndrome. A withdrawal bleed will occur after endometrial stimulation with oestrogens then a progestogen if there is a hypothalamic - pituitary lesion.

Measurement of plasma testosterone is indicated in amenorrhoea associated with hirsutism. Levels greater than 6 nmol/litre suggest ovarian malignancy which must be investigated further. An elevated LH/FSH ration with raised testosterone - but less than 6 nmol/litre - suggests polycystic ovarian syndrome.


progesterone challenge


This is used to assess the ability of the endometrium to respond to steroid hormones.

Medroxyprogesterone acetate - MPA - is given at 10 mg/day p.o. for 5 days.

If withdrawal bleeding occurs 5-7 days later then the endometrium must have been previously exposed to adequate levels of oestrogen, and the endometrium is able to proliferate in response to progesterone. Polycystic ovarian syndrome and hypothalamic dysfunction are the most likely causes of the amenorrhoea, the former being indicated by polycystic ovaries on ultrasound scan.

If no withdrawal bleeding occurs, give oestrogen prior to MPA. A typical regimen would be ethinyloestradiol, 50 æg daily for 21 days with MPA 10 mg daily on days 16-21.

Withdrawal bleeding indicates an oestrogen deficiency state. This may be due to ovarian failure, indicated by raised FSH, or hypothalamic-pituitary failure.

No withdrawal bleeding after the oestrogen / progesterone regime indicates a uterine disorder.


treatment


The treatment of amenorrhoea is of the cause.

Testicular feminisation requires gonadectomy to prevent the risk of malignancy with subsequent hormone replacement. The latter is indicated also, in gonadal dysgenesis and uterine agenesis. These two conditions cannot be "cured" but hormone replacement may lessen their psychological impact considerably. An appropriate low dose combined oral contraceptive pill may be used.

Clomiphene is often effective in cases of the polycystic ovarian syndrome but in extreme cases, surgical intervention e.g. wedge resection or electrodiathermy, may be needed.

In cases of hyperprolactinaemia, a repeat assay is advised as prolactin level may be raised temporarily by stress. Hyperprolactinaemia due to hypothyroidism or drugs resolves resolves on correction of the underlying cause although in the case of phenothiazine, this may take several weeks. In other cases, bromocriptine may be necessary.

Patients with ovarian failure require oestradiol replacement up to the age of the expected menopause. Combined oestrogen and progestogen are advised in women with a uterus to ensure hormone replacement and avoid the risks of endometrial carcinoma.

If spontaneous menstruation does not resume following the attainment of a satisfactory body weight, or cessation of the pill or exercise, clomiphene citrate should be used if the patient wishes to become pregnant.

If the cause is uncertain and either the patient wishes to become pregnant or is anxious about the amenorrhoea, ovulation may be induced using clomiphene, pulsatile GnRH or human gonadotrophins.



4 (Excellent) 3(Good) 2(Good) 1(Bad)   


Recommended Books for PLAB Part 1
• Books to read for PLAB Part 1 by RxPG

Related PLAB Part 1 articles
• What is new in BNF 52?
• Plab 1: March 8, 2006 (Review)
• Top PLAB Part 1 tips for underdogs
• PLAB 1 on 23 January 2006 - Some Facts I witnessed in the exam
• What is New in BNF 50 (September 2005)?
• RxPG Interview With Dr Rashmi Yadav - PLAB Part 1 Topper
• Tips for PLAB1 On 11th NOV 2005
• My Tips After Appearing for PLAB Part 1 on 20 May 2005
• Drug Preparations launched since BNF 49
• What is New in BNF 49 (March 2005)?
• How I Passed my PLAB Part 1 Exam
• Themes of March 8 2005 EMQ and SBA PLAB 1 Paper
• PLAB Part 1 to be held in Iran for the First time
• NICE guidelines for the treatment of osteoporosis in UK
• RxPG Exclusive Review of PLAB exam - September 2004
• Daily SBA (BOF) Mock Test 019
• Daily SBA (BOF) Mock Test 018
• Daily SBA (BOF) Mock Test 017
• Daily SBA (BOF) Mock Test 016
• Daily SBA (BOF) Mock Test 015

Related PLAB Part 1 Discussions

Other articles by Hanna
• Differentiating features of Leukemias (Leukaemias)
• Alphabetical List of past PLAB Part 2 OSCE Stations
• Childhood Diarrhoeas
• Genetic Disorders
• Amenorrhoea
• Management of hypertension

 PLAB Part 1 FAQ
  FAQ: How to Prepare for PLAB 1?
  FAQ: Where to find PLAB Part 1 Past Papers from 2005-2009?
  FAQ: Do you recommend onexamination for PLAB Part 1?
  FAQ: Which is the best online resource for PlAB 1 preparation?
  Browse all FAQs


Write an Article on PLAB Part 1
You can share your exam experiences, preparation strategies, books you have read or just any information about PLAB Part 1 on RxPG website and we will publish it under your name.

Article Rating
Average Score: 4.33
Votes: 3




Most Read Article
How to prepare for PLAB part 1?

Related Links
· First AID for PLAB I
· PLAB Books at Amazon
· GMC Website
· British Council India
· British Council
· BNF
· First Aid at Amazon
· First Aid at Blackwell
· First Aid at Foyles
· PLAB 1 Forum
· Discuss Past Papers
· EMQ Digest at Coop
· First Aid at Medicalbookworld
· First Aid at Kelkoo
· First Aid at Best Book Price
· First Aid at StudentBookWorld
· PLAB 1 Mar 2002
· PLAB 1 May 2002
· PLAB 1 Apr 2003
· PLAB 1 Jan 2003
· PLAB 1 May 2003
· PLAB 1 Nov 2003
· PLAB 1 Sep 2003
· PLAB 1 Jan 2004
· RxPG PLAB Page
· PLAB 1 Mar 2004
· First Aid at nbcindia
· EMQ Digest at nbcindia






ARTICLE TOOLS

· PLAB Part 1 section
· Articles by Hanna
· Add to my pages
· Printer friendly version
· PDF version
· Email article
· Feedback on this article
· Medical tutorials
· Related forum posts
· Related articles
· Related downloads
· Submit article
· PLAB Part 1 alerts
· PLAB Part 1 books
· PLAB Part 1 past papers


Most read story about PLAB Part 1:
How to prepare for PLAB part 1?



Server Status: 77 pages served in last minute. Page generation time: 0.167 seconds

Site Maps: [Books] [News] [Forums] [Reviews] [Mnemonics]

sitemap - top30 - centuries - testimonials


About Us :: Disclaimer :: Contact Us :: Reporting abuse :: Terms of Services :: Privacy Policy

Advertise with RxPG!
Made in India by RxPG Medical Solutions Private Limited

"RxPG" is a Registered Trademark

Chrome Web Store YouTube Twitter LinkedIn Wikipedia Facebook